[EN] QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS<br/>[FR] DÉRIVÉS DE QUINAZOLINONE EN TANT QU'AGENTS ANTIVIRAUX
申请人:GLAXOSMITHKLINE LLC
公开号:WO2012087938A1
公开(公告)日:2012-06-28
Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).
PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME
申请人:ArQule, Inc.
公开号:EP2655372A2
公开(公告)日:2013-10-30
EP2655372B1
申请人:——
公开号:EP2655372B1
公开(公告)日:2016-03-16
US8470786B2
申请人:——
公开号:US8470786B2
公开(公告)日:2013-06-25
[EN] PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME<br/>[FR] COMPOSITIONS DE PYRROLOQUINOLÉINYL-PYRROLIDINE-2,5-DIONE ET PROCÉDÉS POUR PRÉPARER ET UTILISER CEUX-CI
申请人:ARQULE INC
公开号:WO2012088491A2
公开(公告)日:2012-06-28
The present invention relates to pyrroloquinolinyl-pyrrolidine-2,5-dione compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing pyrroloquinolinyl-pyrrolidine-2,5-dione compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds or pharmaceutical compositions to subjects in need thereof.